MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) shares dropped 9.1% on Monday . The stock traded as low as $0.25 and last traded at $0.25. Approximately 300 shares traded hands during trading, a decline of 70% from the average daily volume of 1,000 shares. The stock had previously closed at $0.28.
MDxHealth Stock Performance
The stock has a 50-day moving average price of $0.43. The company has a current ratio of 1.25, a quick ratio of 1.19 and a debt-to-equity ratio of 1.45.
About MDxHealth
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.
Featured Stories
- Five stocks we like better than MDxHealth
- What is a Special Dividend?
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- How to Invest in the Best Canadian StocksĀ
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- Stock Average Calculator
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with MarketBeat.com's FREE daily email newsletter.